Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • sma
    Junior Member
    • Aug 2010
    • 2

    #1

    Terminology question from a novice

    Hi all,

    My lab has recently started using 454 GS FLX titanium pyroseqeuncing of cDNAs for several transcriptome projects with non-model organisms. All of our data has been assembled by Newbler 2.3 and later annotated by search against BLASTx nr database.

    We are debating how we should refer to the assembled "isogroups" in our paper. Is appropriate to refer to an "isogroup" as a gene? Or a 'gene'? What about a isotigs or contigs that are not assembled into isogroups but are annotated?

    Thanks for you help!
  • maubp
    Peter (Biopython etc)
    • Jul 2009
    • 1544

    #2
    As an aside, why are you not using Newbler 2.5? Reportedly it does a better job, see e.g.
    Kumar and Blaxter (2010), http://www.biomedcentral.com/1471-2164/11/571

    Comment

    • flxlex
      Moderator
      • Nov 2008
      • 412

      #3
      I guess the best thing would be to annotate all sequences and cluster them into gene families (or this in reverse order) before calling any two different sequences two different genes or 'genes'...

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 12:22 PM
      0 responses
      12 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-11-2026, 10:35 AM
      0 responses
      13 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...